Keywords: |
cancer chemotherapy; cancer surgery; hydroxyurea; review; cisplatin; doxorubicin; cancer combination chemotherapy; antineoplastic agents; combined modality therapy; methotrexate; bcg vaccine; carboplatin; metastasis; etoposide; antineoplastic combined chemotherapy protocols; lung neoplasms; radiotherapy; cyclophosphamide; vincristine; drug resistance; carmustine; ifosfamide; lomustine; procarbazine; vinblastine; time factors; monoclonal antibody; immunotherapy; brain; lung carcinoma; vinblastine sulfate; thymosin; therapy; intravenous drug administration; small cell carcinoma; drug indication; carcinoma, small cell; respiratory system; human; iproplatin; support, u.s. gov't, p.h.s.; corynebacterium parvum
|